Source:http://linkedlifedata.com/resource/pubmed/id/14611974
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2003-11-12
|
pubmed:abstractText |
Allograft nephropathy leads to progressive renal injury and ultimate graft loss. In native kidney disease, the use of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) is beneficial in retarding the decline of renal function. We reviewed a cohort of renal transplant recipients who were prescribed either an ACEi or ARB for biopsy-proven allograft nephropathy. Patients were followed from time of initiation of ACEi/ARB and were stratified based on biopsy findings. Outcomes of interest included safety, allograft survival, renal function, and rate of renal function decline pre- and post-ACEi/ARB. The 5-year allograft survival after biopsy was 83%. Mean serum creatinine was 2.2 +/- 1.1 mg/dL (range 1.0 to 4.3) at time of biopsy and 2.6 +/- 1.2 mg/dL (1.2 to 6.5) at last follow-up. The mean slope of the creatinine versus time (SD) was 2.43 (7.93) in the 12 months prior to therapy and 1.45 (3.66) following therapy, with the absolute difference in slope -3.38 (6.06) (P =.0004). We conclude that treatment with ACEi/ARB is beneficial in the management of allograft nephropathy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0041-1345
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2415-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:14611974-Angiotensin Receptor Antagonists,
pubmed-meshheading:14611974-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:14611974-Biopsy,
pubmed-meshheading:14611974-Chronic Disease,
pubmed-meshheading:14611974-Creatinine,
pubmed-meshheading:14611974-Humans,
pubmed-meshheading:14611974-Kidney Transplantation,
pubmed-meshheading:14611974-Postoperative Complications,
pubmed-meshheading:14611974-Renin-Angiotensin System,
pubmed-meshheading:14611974-Retrospective Studies
|
pubmed:year |
2003
|
pubmed:articleTitle |
Renin-angiotensin system blockade in biopsy-proven allograft nephropathy.
|
pubmed:affiliation |
Renal Transplant Program, Division of Nephrology, St Michael's Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. jeffrey.zaltzman@utoronto.ca
|
pubmed:publicationType |
Journal Article
|